TY - JOUR T1 - A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine. AU - Mukherjee,Aveek, AU - Ahmad,Mudassar, AU - Frenia,Douglas, Y1 - 2020/03/30/ PY - 2020/5/1/entrez PY - 2020/5/1/pubmed PY - 2020/5/1/medline KW - 2019 novel coronavirus KW - 2019-ncov KW - cov KW - covid-19 KW - ground-glass opacity KW - hydroxychloroquine KW - multifocal KW - pneumonia KW - sars-cov-2 (severe acute respiratory syndrome coronavirus -2) KW - wuhan SP - e7473 EP - e7473 JF - Cureus JO - Cureus VL - 12 IS - 3 N2 - After an outbreak in December 2019 in Wuhan, Hubei Province of China, coronavirus disease 2019 (COVID-19) has rapidly become a pandemic. The 2019 novel coronavirus (2019 nCov), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a wide spectrum of illness and patients with underlying comorbidities have a high mortality. Here we present a 49-year-old male patient with comorbid conditions who presented with fever, cough, myalgia and shortness of breath for five days with likely exposure to a COVID-19 contact. A computed tomography scan of the thorax revealed multifocal bilateral ground-glass lung opacities with areas of subpleural sparing. He tested positive for SARS-CoV-2 by nucleic acid amplification. Hydroxychloroquine therapy was started, and the patient responded favorably with improvement of symptoms. Early diagnosis and self-isolation or quarantine remain key to stemming the tide of the contagion as there is a real risk of the healthcare system being overwhelmed. SN - 2168-8184 UR - https://www.unboundmedicine.com/medline/citation/32351851/A_Coronavirus_Disease_2019__COVID_19__Patient_with_Multifocal_Pneumonia_Treated_with_Hydroxychloroquine_ DB - PRIME DP - Unbound Medicine ER -